The Critical and Well-Compensated Role of Whistleblowers in Exposing Injustice

Upholding Accountability and Safeguarding Public Interest Whistleblowers have long been unsung heroes in the fight against corruption, injustice, and wrongdoing. A recent Delray Beach case related to contaminated water systems in Florida illustrates the essential role whistleblowers play in upholding the public’s right to safety and transparency, and the courage required to stand up against

2023-04-10T18:47:08+00:00April 10th, 2023|Whistleblower Law|

Lieff Cabraser Announces $70.7 Million Settlement of Qui Tam Misuse of Government Funds Litigation with Gold Coast Health Plan and Certain California Medical Providers

Gold Coast (aka Ventura County Medi-Cal Managed Care Commission) to pay $17.2 million to U.S. and California; providers that received allegedly illegal payments – Ventura County Medical Center, Dignity Health, and Clinicas del Camino Real Inc. – will pay an additional $53.5 million August 19, 2022, San Francisco–(BUSINESSWIRE)–The law firm of Lieff Cabraser Heimann &

2022-08-19T17:39:07+00:00August 19th, 2022|Firm News, Whistleblower Law|

U.S. Attorney Announces $12.9 Million Settlement With New York City Health Services Provider The Door For Submitting Fraudulent Cost Reports

Complaint in the case alleged The Door falsely inflated the number of visits to its facility on cost reports in order to fraudulently receive additional undeserved reimbursement money from the Indigent Care Pool In a press release issued today, the U.S. Attorney’s office has announced that the United States filed and settled a civil fraud

2022-02-03T23:31:39+00:00February 3rd, 2022|Whistleblower Law|

NHTSA Awards $24.3M to Whistleblower, First in History

The National Highway Traffic Safety Administration (NHTSA) has announced it will be paying out a whistleblower award to a former Hyundai safety engineer who reported an engine defect in 2016, which Hyundai failed to address, that was causing vehicles to seize up and even catch fire. NHTSA found that Korean car manufacturer Hyundai and its

2021-11-09T19:57:06+00:00November 9th, 2021|Whistleblower Law|

New York Governor Hochul Signs New Legislation Protecting Employees from Retaliation

New York Governor Kathy Hochul has enacted legislation that protects employees in the state from retaliatory actions for reporting illegal or dangerous business activities. In meaningfully amending the prior law, there are multiple important and noteworthy aspects of the new law that together give crucial support to whistleblowers.

2021-10-29T18:27:40+00:00October 29th, 2021|Employment Law, Whistleblower Law|

Lieff Cabraser Represents Whistleblower-Relator in Nashville-Area Hospice Medical Fraud Lawsuit

After eight years of delays, the federal and state governments have intervened in the concealed overpayments lawsuit against two Nashville-based hospice care providers and their parent company. The suit alleges that Nashville-based Avalon Hospice, Brentwood-based Regency Health Care Group and Curo Health Services, along with its parent, pressured staff to “conceal overpayments to maximize census

2021-06-04T23:54:40+00:00June 4th, 2021|Whistleblower Law|

AbbVie Agrees to $24 Million Settlement with California Department of Insurance and Whistleblower Over Humira Marketing Fraud

Lawsuit alleged AbbVie pharmaceutical company committed fraud in promotion of blockbuster prescription drug Humira The California Department of Insurance has announced a settlement agreement with AbbVie Inc. to resolve a lawsuit alleging the pharmaceutical giant violated the California Insurance Frauds Prevention Act (Act) by providing kickbacks to healthcare providers throughout California relating to the sale of its

2020-09-21T15:37:09+00:00September 21st, 2020|Whistleblower Law|

AbbVie Medical Fraud Lawsuit Highlights Growing Nationwide Concern With Big Pharma Paying Doctors to Get New Customers

As reported by USA Today, there is a growing concern across the U.S. over the apparent surge in dangerous and highly expensive medications being pushed on the public by drug manufactures whose main concern is not turning a new corner in patient health but rather turning over millions in profits.

2019-08-13T14:54:56+00:00August 13th, 2019|Whistleblower Law|